Fundraising Fox
/Companies
Sign in

Reshape Biotech

YC W21

Copenhagen, DK · Founded 2018 · 40 employees · 8 known investors

Find your way into Reshape Biotech

Sign up to see every warm intro you have to Reshape Biotech

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Reshape Biotech team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Reshape provides an AI-driven operating system that automates microbiology data capture and analysis for research laboratories. The platform structures experimental results and surfaces insights to help lab teams accelerate research and product development.

AI & Machine LearningBiotechDeep TechHealthtechRoboticsDenmarkEuropePartly Remote

Founders & leadership· Y Combinator alumni (W21)

Reshape Biotech was founded in 2018 by Carl-Emil Grøn Fuglesang, Magnus Nyborg Madsen, and Daniel Storgaard.

CGCarl-Emil Grøn Fuglesang
Carl-Emil Grøn FuglesangFounderCarl-Emil Grøn Fuglesang holds degrees in mechanical engineering and physics, and serves as CEO of Reshape Biotech.
MNMagnus Nyborg Madsen
Magnus Nyborg MadsenCo-founder · Chief Customer OfficerMagnus Nyborg Madsen founded Reshape Biotech to develop laboratory automation solutions. His background includes interests in robotics and automation applied to life sciences research.
DSDaniel Storgaard
Daniel StorgaardCo-FounderDaniel Storgaard oversees product development and project management at Reshape Biotech, with responsibilities spanning quality assurance, customer engagement, financial planning, and accounting.
CG
Carl-Emil GronFounder

Investors · 8

ACME Capitallisted by ACME CapitalSan Francisco

How we know: ACME Capital's portfolio page · a partner's Signal profile · siliconrepublic.com · the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Astanor Ventureslisted by Astanor VenturesBrussels

How we know: Astanor Ventures's portfolio page · tech.eu · Y Combinator's founder network · Not right? Tell us

FundersClublisted by FundersClubSan Francisco · $290K

How we know: FundersClub's portfolio page · Y Combinator's founder network · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · siliconrepublic.com · open dataset · 5k.vc investor directory · Not right? Tell us

Berggruen HoldingsreportedLos Angeles · $200M

How we know: Y Combinator's founder network · Not right? Tell us

R7 PartnersreportedChicago · $100K – $5M

How we know: the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Also in the syndicate · 2

21stBioR7

Funding

SEC filings, press & company announcements

$20M disclosed across 1 of 2 rounds · 2023–2024

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 6

OpentronsOpentrons develops laboratory robots that automate scientific research tasks for scientists and research institutions. The company aims to democratize access to laboratory automation and increase the availability of robotic systems to accelerate discovery in life sciences.
NeuromorphicNeuromorphic develops hardware-agnostic control software for robots, letting operators deploy and manage them through everyday interfaces such as Slack, email, and phone. It targets wet labs and other physical industries that want to add robots with minimal setup.
TranscripticStrateos operates a cloud lab platform offering laboratory automation-as-a-service, using high-throughput robotics that let scientists design, run, and analyze experiments remotely via a web browser. It serves pharmaceutical companies, biotechs, startups, academia, CROs, and AI drug discovery teams in the life sciences.
Future FieldsFuture Fields uses fruit flies as bioreactors to produce difficult-to-express proteins at scale for pharmaceutical, agricultural, and food applications. The company aims to enable the development of novel biological products across healthcare, agriculture, and nutrition sectors.
NobelprizeNobelprize.org provides open data about the Nobel Prizes and Nobel Laureates to developers through a REST API and as Linked Data (RDF/SPARQL). The data is free to use, returned in JSON or CSV, and updated alongside the main website including at the time of new Laureate announcements.
Brown FoodsUnreal Milk produces lab-grown whole cow milk using cellular agriculture technology. The company targets consumers seeking sustainable dairy alternatives.

Companies working in the same space as Reshape Biotech.

Legal entities · 1

corporate structure
Reshape Biotech Inc.

In the news

Reshape wants to help ‘decode nature’ by automating the ‘visual’ part of lab experiments | TechCrunchtechcrunch.com · Apr 2024

Frequently asked questions

What does Reshape Biotech do?
Reshape provides an AI-driven operating system that automates microbiology data capture and analysis for research laboratories. The platform structures experimental results and surfaces insights to help lab teams accelerate research and product development.
Who founded Reshape Biotech?
Reshape Biotech was founded by Carl-Emil Grøn Fuglesang, Magnus Nyborg Madsen, Daniel Storgaard in 2018.
Who are Reshape Biotech's investors?
Reshape Biotech's investors include ACME Capital, Astanor Ventures, FundersClub, Y Combinator, Berggruen Holdings, R7 Partners.
How much funding has Reshape Biotech raised?
Reshape Biotech has disclosed $20M raised across 1 of its 2 known rounds.
Where is Reshape Biotech headquartered?
Reshape Biotech is headquartered in Copenhagen, DK.